Global Health

Ivermectin: Still on a Losing Streak as COVID-19 Treatment | MedPage Today

WASHINGTON -- There were no differences in relief from mild-to-moderate COVID-19 symptoms for patients on ivermectin versus placebo, according to the ongoing ACTIV-6 trial.

Among >1,000 vaccinated and unvaccinated patients, the median time to recovery was 12 days for those in the ivermectin group and 13 days in the placebo group, reported Matthew McCarthy, MD, of Weill Cornell Medicine in New York City, at IDWeek.

As a result, the hazard ratio for improvement in time to recovery was 1.07 (95% credible interval 0.96-1.17, posterior P=0.91), McCarthy and colleagues stated in JAMA, where the results were simultaneously published.

...

The main COVID symptoms have changed, research shows | The Hill

 ... like all viruses, the primary symptoms associated with COVID have changed and can vary based on your vaccination status, according to a new list released last week.

...

Researchers have found that for participants in all three groups — fully vaccinated, those who received just one dose, and unvaccinated — four of the five most commonly reported symptoms are the same: sore throat, runny nose, persistent cough, and headache.

Their prevalences across the groups, however, vary, as does the fifth symptom.

For those who are vaccinated, a blocked nose is the third-most frequently reported symptom. Among the partially vaccinated, it’s sneezing, and the unvaccinated, fever.

Below are the symptoms most commonly reported among the three groups, ranked in order of how often they are reported.  ...

Cases of BQ.1, BQ.1.1 COVID variants double in U.S. as Europe warns of rise U.S. regulators estimated BQ.1 and closely related BQ.1.1 accounted for 16.6% of COVID variants in the country, nearly doubling from last week, as Europe expects them to become dominant in a month. Manas Mishra,Khushi Mandowara Reuters

...

Cholera outbreak hits Syrian refugees sheltering in camps in Lebanon Syrian refugees in displacement camps are falling victim to a cholera outbreak in Lebanon, already suffering from an economic meltdown that has slashed access to clean water and strained hospitals. Maya Gebeily Reuters

...